9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized R&D costs are reported between ~$1.1B median and ~$2.2B+ per asset in large-pharma cohorts for a new medicine to complete the journey from initial discovery …

Toronto’s Blossoming AI-driven Drug Discovery Scene

Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep into the history of early programs and funding provided by Canadian Institute for Advanced Research (CIFAR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to such AI …

Contract Research Organizations Tap Into AI To Increase Value Proposition

A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to get a drug or medical device to market. Nowadays, nearly any type of R&D or regulatory filing work that a drug maker or a medical-device producer needs to do -- …

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space

(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a notable amount of activity over the last several years with a considerable number of initiated research collaborations between AI-driven R&D vendors and top …